Third Generation EGFR TKIs for Acquired Resistance
Video
Dr. Nathan Pennell, Cleveland Clinic, discusses the concept of acquired resistance and new agents designed to address it, including Rociletinib and Merelitinib.
Dr. Nathan Pennell, Cleveland Clinic, discusses the concept of acquired resistance and new agents designed to address it, including Rociletinib and Merelitinib.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock